نتایج جستجو برای: ibandronate sodium ibn

تعداد نتایج: 191873  

Journal: :analytical and bioanalytical chemistry research 2015
priyanka bose suddhasattya dey souvik basak shreya shah anjan de

the present study describes a simple, accurate, precise and cost effective uv-vis spectroscopic and rp-hplc method for the estimation of ibandronate sodium (ibn). the determination of ibandronate sodium (ibn) was performed by both uv and rp-hplc method using 215 nm as the determination wavelength. the drug was dissolved in naoh solution (0.1n naoh) for estimation in uv and in distilled water fo...

2015
In-Jin Cho Ho-Yeon Chung Sung-Woon Kim Jae-Won Lee Tae-Won Lee Hye-Soon Kim Sin-Gon Kim Han Seok Choi Sung-Hee Choi Chan Soo Shin Ki-Won Oh Yong-Ki Min Jung-Min Koh Yumie Rhee Dong-Won Byun Yoon-Sok Chung Jeong Hyun Park Dong Jin Chung Minho Shong Eun-Gyoung Hong Chang Beom Lee Ki Hyun Baek Moo-Il Kang

BACKGROUND The present study evaluated the efficacy of a combination of ibandronate and cholecalciferol on the restoration of the levels of 25-hydroxyvitamin D (25[OH]D) and various bone markers in postmenopausal women with osteoporosis. METHODS This was a randomized, double-blind, active-controlled, prospective 16-week clinical trial conducted in 20 different hospitals. A total of 201 postme...

The present study describes a simple, accurate, precise and cost effective UV-Vis Spectroscopic and RP-HPLC method for the estimation of Ibandronate sodium (IBN). The determination of Ibandronate sodium (IBN) was performed by both UV and RP-HPLC method using 215 nm as the determination wavelength. The drug was dissolved in NaOH solution (0.1N NaOH) for estimation in UV and in distilled water fo...

Journal: :Onkologie 2008
Marcus Neudert Christian Fischer Burkhard Krempien Markus J Seibel Frieder Bauss

BACKGROUND Using a nude rat model of site-specific metastatic bone disease (MBD), we developed a semiquantitative histological score for rapid assessment of lytic lesions in bone. This provides additional information to conventional histological measurement by clarifying the extent and location of metastatic infiltration and the tumor growth pattern. The score can also be used to assess the act...

Journal: :Bone 2010
Mohammad Shahnazari Wei Yao WeiWei Dai Bob Wang Sophi S Ionova-Martin Robert O Ritchie Daniel Heeren Andrew J Burghardt Daniel P Nicolella Michael G Kimiecik Nancy E Lane

We report the results of a series of experiments designed to determine the effects of ibandronate (Ibn) and risedronate (Ris) on a number of bone quality parameters in aged osteopenic rats to explain how bone material and bone mass may be affected by the dose of bisphosphonates (BP) and contribute to their anti-fracture efficacy. Eighteen-month old female rats underwent either ovariectomy or sh...

Journal: :Journal of gastrointestinal and liver diseases : JGLD 2011
Jochen Klaus Max Reinshagen Katharina Herdt Guido Adler Georg B T von Boyen Christian von Tirpitz

BACKGROUND AND AIM Osteoporosis commonly afflicts Crohn's disease (CD) patients. Management remains unclear, with limited results for intravenous (i.v.) bisphosphonates and a follow-up longer than one year. Intravenous bisphosphonates bypass gastrointestinal-tract irritation offering an interesting alternative suitable for CD patients. We tested the long-term efficacy and safety of colecalcifer...

2013
Jaya Shukla

Bisphosphonates are established as supportive therapy to reduce the frequency and severity of cancer-related skeletal complications. Oral formulations are preferred over intravenous if the patients are not hospitalized. The maximum absorption of oral bisphosphonates takes place in stomach. The adverse events with oral dosing are seen in buccal mucosa and gastrointestinal tract, which lead to po...

Journal: :Journal of cancer research and therapeutics 2010
Rudolf Weide Hubert Koppler Lucia Antras Michael Smith M P H Eva Chang Jesse Green Neil Wintfeld Maureen P Neary Mei Sheng Duh

AIMS This retrospective study investigated the rates of renal impairment in patients with multiple myeloma treated with zoledronic acid and ibandronate. MATERIALS AND METHODS We retrospectively reviewed medical records in a German oncology clinic, from May 2001 to December 2005. Creatinine measurements were analyzed from baseline (before zoledronic acid or ibandronate treatment) to last evalu...

Journal: :Annals of the rheumatic diseases 2003
J A Stakkestad L I Benevolenskaya J J Stepan A Skag A Nordby E Oefjord A Burdeska I Jonkanski P Mahoney

OBJECTIVE To investigate the efficacy, safety, and dose response of three doses of ibandronate, given intermittently by intravenous (IV) injection every three months, in preventing postmenopausal osteoporosis. PATIENTS AND METHODS 629 postmenopausal women, categorised according to time since menopause and baseline lumbar spine (L1-4) bone mineral density (BMD), were enrolled into a multicentr...

2015
Chun-Jing Geng Qian Liang Jian-Hong Zhong Min Zhu Fan-Ying Meng Ning Wu Rui Liang Bin-Yi Yuan

OBJECTIVE Randomised controlled trials (RCTs) have given contradictory results about the efficacy and safety of ibandronate in treating metastatic bone disease (MBD) or multiple myeloma. This review meta-analysed the literature to gain a more comprehensive picture. DESIGN Systematic review and meta-analysis of ibandronate compared with placebo or zoledronate. DATA SOURCES PubMed, EMBASE and...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید